feed,title,long_url,short_url
Investors,"Biotech Stocks Madrigal, Altimmune In A Tizzy As New Weight-Loss Rival Enters The Arena",https://www.investors.com/news/technology/biotech-stocks-diverge-on-new-results-for-weight-loss-drug-in-mash-patients/,https://da.gd/e5iaJ4
